TipRanks
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market
CHRS
Coherus Biosciences
RESEARCH TOOLSreports
Want to see CHRS full AI Analyst Report?

Coherus Biosciences (CHRS) Balance Sheet

1,699 Followers

Coherus Biosciences Balance Sheet

Coherus Biosciences's total assets for Q2 2026 were $191.18M, a decrease of -28.13% from the previous quarter. CHRS total liabilities were $130.34M for the fiscal quarter, a -30.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 258.34M$ 448.53M$ 629.60M$ 480.85M$ 679.33M
Total Liabilities
$ 197.33M$ 580.52M$ 823.03M$ 618.26M$ 581.61M
Total Equity Gross Minority
$ 61.01M$ -131.99M$ -193.43M$ -137.42M$ 97.73M
Other Metrics
Currency in USD

Coherus Biosciences Debt to Assets